Suicidality and anxiety sensitivity in adults with HIV.

Suicide rates among HIV-positive individuals are more than three times higher than in the general population. Anxiety sensitivity (AS) may be clinically relevant to increasing our understanding of suicide among individuals with HIV. Specifically, relations between AS cognitive concerns and suicide related outcomes have been observed across a range of populations. The current investigation sought to examine the effect of AS and individual AS subfactors (i.e., cognitive, physical, and social concerns) in relation to suicidality in a sample of adults with HIV. Participants were 164 adults with HIV (17.1% women; mean age=48.40) recruited from AIDS service organizations in Vermont/New Hampshire and New York City. Findings from the current study indicate that AS cognitive concerns (β=0.46, p=0.001), but not the global AS factor, are positively associated with elevated rates of suicidality among persons with HIV above and beyond demographics, HIV relevant factors, and negative affectivity. There was also a negative trend for AS physical concerns in terms of suicidality (β=-0.25, p=0.07). Clinicians may benefit from implementing AS reduction strategies with HIV-positive persons who endorse elevated suicide risk as well as elevated AS cognitive concerns. The current study is limited by a cross-sectional design and lack of suicide attempt history. Future work would benefit from longitudinal examination of the observed relations, further inquiry regarding the relation between AS physical concerns and suicidality and a more comprehensive assessment of suicidality.

[1]  Daniel W Capron,et al.  Role of anxiety sensitivity subfactors in suicidal ideation and suicide attempt history , 2012, Depression and anxiety.

[2]  M. Zvolensky,et al.  HIV symptom distress and anxiety sensitivity in relation to panic, social anxiety, and depression symptoms among HIV-positive adults. , 2012, AIDS patient care and STDs.

[3]  Daniel W Capron,et al.  An interactive model of anxiety sensitivity relevant to suicide attempt history and future suicidal ideation. , 2012, Journal of psychiatric research.

[4]  J. Castilla,et al.  Mortality by causes in HIV-infected adults: comparison with the general population , 2011, BMC public health.

[5]  Carol T. Miller,et al.  A Preliminary Examination of Sexual Orientation as a Social Vulnerability for Experiencing HIV/AIDS-related Stigma. , 2011, Journal of applied social psychology.

[6]  I. Galynker,et al.  Panic as an independent risk factor for suicide attempt in depressive illness: findings from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). , 2011, The Journal of clinical psychiatry.

[7]  M. Gill,et al.  Domestic violence screening: prevalence and outcomes in a Canadian HIV population. , 2010, AIDS patient care and STDs.

[8]  Jitender Sareen,et al.  The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions , 2010, Depression and anxiety.

[9]  M. Otto,et al.  A meta‐analytic review of the association between anxiety sensitivity and pain , 2010, Depression and Anxiety.

[10]  Kelly C. Cukrowicz,et al.  The interpersonal theory of suicide. , 2010, Psychological review.

[11]  M. Egger,et al.  Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. , 2010, The American journal of psychiatry.

[12]  A. Carrico Elevated suicide rate among HIV-positive persons despite benefits of antiretroviral therapy: implications for a stress and coping model of suicide. , 2010, The American journal of psychiatry.

[13]  A. Osman,et al.  The Anxiety Sensitivity Index–3: Analyses of Dimensions, Reliability Estimates, and Correlates in Nonclinical Samples , 2010, Journal of personality assessment.

[14]  Carol T. Miller,et al.  Exploration of the Relevance of Anxiety Sensitivity among Adults Living with HIV/AIDS for Understanding Anxiety Vulnerability , 2010, Journal of health psychology.

[15]  J. Cougle,et al.  Anxiety disorders and suicidality in the National Comorbidity Survey-Replication. , 2009, Journal of psychiatric research.

[16]  R. Remien,et al.  Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy , 2008, Brain, Behavior, and Immunity.

[17]  M. Zvolensky,et al.  An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacy. , 2008, Journal of anxiety disorders.

[18]  D. Watson,et al.  Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). , 2007, Psychological assessment.

[19]  Steven Taylor,et al.  Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. , 2007, Psychological assessment.

[20]  Wayne T. Steward,et al.  Correlates of suicidal ideation among HIV-positive persons , 2007, AIDS.

[21]  T. Patterson,et al.  The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART , 2007, AIDS.

[22]  J. Buckner,et al.  Anxiety Sensitivity As a Prospective Predictor of Alcohol Use Disorders , 2007, Behavior modification.

[23]  C. Koopman,et al.  Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS , 2007, AIDS care.

[24]  M. Zvolensky,et al.  Anxiety sensitivity: prospective prediction of panic attacks and Axis I pathology. , 2006, Journal of psychiatric research.

[25]  W. Breitbart,et al.  Desire for hastened death among patients with advanced AIDS. , 2006, Psychosomatics.

[26]  M. Zvolensky,et al.  Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users. , 2006, Behaviour research and therapy.

[27]  Stacey B. Daughters,et al.  The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. , 2006, Behaviour research and therapy.

[28]  T. Hawkins Appearance-related side effects of HIV-1 treatment. , 2006, AIDS patient care and STDs.

[29]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[30]  J. Gallo,et al.  Completed suicide after a suicide attempt. , 2005, The American journal of psychiatry.

[31]  K. Lynch,et al.  The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. , 2005, Archives of general psychiatry.

[32]  A. Wu,et al.  Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. , 2004, Psychosomatics.

[33]  S. Kegeles,et al.  Experiences of harassment, discrimination, and physical violence among young gay and bisexual men. , 2004, American journal of public health.

[34]  M. Sharpe,et al.  Psychological autopsy studies of suicide: a systematic review , 2003, Psychological Medicine.

[35]  A. Wu,et al.  Development and validation of a self-completed HIV symptom index. , 2001, Journal of clinical epidemiology.

[36]  C. Sherbourne,et al.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. , 2001, Archives of general psychiatry.

[37]  M. Bates,et al.  Evaluating panic-specific factors in the relationship between suicide and panic disorder. , 2001, Behaviour research and therapy.

[38]  S. Taylor,et al.  Anxiety sensitivity and depression: how are they related? , 1996, Journal of abnormal psychology.

[39]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[40]  T. Hart,et al.  HIV and Anxiety , 2008 .

[41]  T. Joiner Why People Die by Suicide , 2005 .

[42]  D. Fuchs,et al.  Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. , 2002, Clinical immunology.

[43]  R. Rapee,et al.  Anxiety sensitivity, panic, and depressed mood: a reanalysis teasing apart the contributions of the two levels in the hierarchial structure of the Anxiety Sensitivity Index. , 2001, Journal of abnormal psychology.

[44]  D. Watson Mood and temperament , 2000 .

[45]  S. Reiss,et al.  Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. , 1986, Behaviour research and therapy.